Principal Securities’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Buy
+2,383
New +$209K ﹤0.01% 1503
2025
Q4
Sell
-1,881
Closed -$185K 3561
2025
Q3
$185K Sell
1,881
-106
-5% -$10.5K ﹤0.01% 1323
2025
Q2
$181K Sell
1,987
-146
-7% -$14.1K ﹤0.01% 1269
2025
Q1
$225K Hold
2,133
0.01% 1081
2024
Q4
$225K Buy
2,133
+409
+24% +$43.9K 0.01% 1081
2024
Q3
$186K Sell
1,724
-394
-19% -$43K ﹤0.01% 1133
2024
Q2
$230K Sell
2,118
-93
-4% -$11K 0.01% 990
2024
Q1
$292K Buy
2,211
+264
+14% +$33K 0.01% 872
2023
Q4
$237K Buy
+1,947
New +$217K 0.01% 880

Other funds holding ZBH

Principal Securities's ZBH Position: Q2 2026 in Review

Principal Securities opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 2,383 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #1503 among its holdings. This is a return to the name: Principal Securities previously reported a position in ZBH as recently as Q3 2025.

Principal Securities first reported a position in ZBH in Q4 2023 and has held it in 9 quarters since. The position peaked at $292K in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Principal Securities held 2,383 shares of Zimmer Biomet worth $205K as of Q2 2026.
  • Zimmer Biomet was a new Principal Securities position in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Principal Securities's portfolio in Q2 2026, its #1503 holding.
  • Principal Securities first reported a position in Zimmer Biomet in Q4 2023 and has held it in 9 quarters since.
  • Principal Securities's Zimmer Biomet position peaked at $292K in Q1 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.